Morris ER, Caswell SJ, Kunzelmann S, Arnold LH, Purkiss AG, Kelly G, et al
Schedule prompt medical evaluation (within 24-48 hours) for: Gradually worsening shortness of breath over days to weeks Dyspnea with exertion that is new or significantly worse than baseline Breathing difficulty accompanied by persistent cough or fever Leg swelling, weight gain, or orthopnea (difficulty breathing when lying flat) Respiratory symptoms associated with severe ongoing nausea, vomiting, or inability to maintain hydration Patients should not discontinue GLP-1 medications without medical guidance (except in cases of suspected severe allergic reactions), but should contact their healthcare provider promptly to discuss respiratory symptoms
The comparison between berberine and prescription GLP-1 medications reveals fundamental differences in mechanism, potency, evidence base, and regulatory status
Take one capsule twice a day before meals or as directed by a healthcare professional